| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |